Dr. Jeffrey Scott Brackeen , MD
Dermatology • Lubbock, TX
4709 66th St
Lubbock, TX 794144877
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 16, 2007; this date does not establish years in practice.
-
Published CMS data list 13,321 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J7345 — Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg: 8,000 service units.
- 17003 — Destruction of precancer skin growth, 2-14 growths: 2,498 service units.
- 99213 — Established patient outpatient office visit: 925 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 19 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,156 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Triamcinolone Acetonide — 232 prescription fills, including refills.
- Clobetasol Propionate — 178 prescription fills, including refills.
- Ketoconazole — 114 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 28 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Dermatology in Lubbock, TX (2024, 11 clinicians with data). Median for this group: 9,809. Middle half: 5,000 to 12,013.
More Medicare Part B services than 95% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: 2,197. Middle half: 1,083 to 4,729.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 14,363 in 2020 to 13,321 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
4709 66th St
Lubbock, TX 794144877
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Skin Cancer Institute Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Texas A & M University System, Hsc, College Of Medicine
2000
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
994 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $294,791 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $206,259 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,361 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$701,927 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,337.63 across 78 records.
By nature of payment
- Food and Beverage: $1,265.63 across 77 records.
- Education: $72.00 across 1 record.
Reporting-company totals (3 largest of 16)
- Janssen Pharmaceuticals, Inc: $267.36 across 20 records.
- ABBVIE INC.: $183.42 across 10 records.
- Galderma Laboratories, L.P.: $153.81 across 14 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
26 years (graduated 2000)
CMS Doctors and Clinicians data list 2000 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Brackeen has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Brackeen as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Lubbock and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Dermatology in Lubbock, TX (2024, 11 clinicians with data). Median for this group: 9,809. Middle half: 5,000 to 12,013.
More Medicare Part B services than 95% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: 2,197. Middle half: 1,083 to 4,729.
Medicare-allowed amount
A lower Medicare-allowed amount than 60% of clinicians listed under Dermatology in Lubbock, TX (2024, 11 clinicians with data). Median for this group: $429,160. Middle half: $240,818 to $821,253.
A higher Medicare-allowed amount than 75% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: $135,436. Middle half: $65,432 to $291,321.
Paid by Medicare
A lower Medicare payment amount than 60% of clinicians listed under Dermatology in Lubbock, TX (2024, 11 clinicians with data). Median for this group: $316,789. Middle half: $165,410 to $600,911.
A higher Medicare payment amount than 70% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: $95,793. Middle half: $45,476 to $209,429.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Dermatology in Lubbock, TX (2024, 11 clinicians with data). Median for this group: 949. Middle half: 825 to 1,120.
More Part D prescriptions than 80% of clinicians listed under Dermatology in Texas (2024, 934 clinicians with data). Median for this group: 479. Middle half: 197 to 946.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Lubbock, TX (2024, 11 clinicians with data). Median for this group: $105,216. Middle half: $51,562 to $185,665.
A higher Part D drug cost than 90% of clinicians listed under Dermatology in Texas (2024, 934 clinicians with data). Median for this group: $79,996. Middle half: $6,799 to $221,327.
13 active clinicians are listed under Dermatology with a practice address in Lubbock, TX (1,195 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Lubbock
0% of these 13 clinicians have the CMS telehealth indicator.
92.3% of these 13 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 14,363 in 2020 and 13,321 in 2024.
- 2020: 14,363
- 2021: 17,143
- 2022: 15,881
- 2023: 17,262
- 2024: 13,321
-
Medicare-allowed amount
Medicare-allowed amount increased 19% from $247,635 in 2020 to $294,791 in 2024.
- 2020: $247,635
- 2021: $245,376
- 2022: $271,289
- 2023: $298,825
- 2024: $294,791
-
Paid by Medicare
Paid by Medicare increased 16% from $178,095 in 2020 to $206,259 in 2024.
- 2020: $178,095
- 2021: $175,949
- 2022: $183,723
- 2023: $208,926
- 2024: $206,259
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 48% from 779 in 2020 to 1,156 in 2024.
- 2020: 779
- 2021: 775
- 2022: 812
- 2023: 981
- 2024: 1,156
-
30-day fills
30-day fills increased 65% from 822 in 2020 to 1,361 in 2024.
- 2020: 822
- 2021: 828
- 2022: 909
- 2023: 1,091
- 2024: 1,361
-
Part D drug cost
Part D drug cost increased 158% from $272,057 in 2020 to $701,927 in 2024.
- 2020: $272,057
- 2021: $201,091
- 2022: $386,251
- 2023: $360,932
- 2024: $701,927
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $739.86 in 2021 to $1,337.63 in 2025.
- 2021: $739.86
- 2022: $1,114.76
- 2023: $1,332.51
- 2024: $1,235.96
- 2025: $1,337.63
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 78 records totaling $1,337.63.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $72.00 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $33.95 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $33.39 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $31.86 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $31.54 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $31.49 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $30.90 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
— | General | $29.05 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $28.83 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $28.79 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $28.74 |
| Almirall LLC |
Food and Beverage
In-kind items and services
|
Klisyri | General | $27.03 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $26.50 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
VTAMA | General | $25.40 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $25.24 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $24.53 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TALTZ | General | $24.14 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $23.93 |
| Organogenesis Inc. |
Food and Beverage
In-kind items and services
|
AFFINITY | General | $23.50 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
— | General | $23.21 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
VTAMA | General | $23.16 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $23.07 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $20.80 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Rhapsido | General | $20.62 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $20.57 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J7345
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
|
8,000 | 23 | $1.80 | $1.62 |
|
17003
Destruction of precancer skin growth, 2-14 growths
|
2,498 | 415 | $13.32 | $6.48 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
925 | 699 | $179.21 | $89.33 |
|
17000
Destruction of precancer skin growth, 1 growth
|
656 | 502 | $130.08 | $56.96 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
251 | 185 | $248.23 | $125.84 |
|
17110
Destruction of skin growth, 1-14 growths
|
216 | 196 | $217.66 | $110.31 |
|
11102
Biopsy of related skin growth, first growth
|
178 | 159 | $191.71 | $93.52 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
153 | 110 | $109.02 | $55.66 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
118 | 118 | $220.15 | $109.22 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
95 | 71 | $337.04 | $162.74 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
63 | 63 | $323.31 | $165.04 |
|
96567
Application of light to destroy precancer skin growth
|
36 | 22 | $256.57 | $128.50 |
|
11103
Biopsy of related skin growth, each additional growth
|
30 | 22 | $95.99 | $49.19 |
|
17262
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
|
28 | 21 | $361.33 | $151.03 |
|
69100
Biopsy of ear
|
19 | 18 | $182.51 | $86.25 |
|
17111
Destruction of skin growth, 15 or more growths
|
16 | 14 | $254.98 | $130.84 |
|
11104
Punch biopsy, first skin growth
|
14 | 14 | $239.52 | $118.18 |
|
12032
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
|
14 | 14 | $584.04 | $256.62 |
|
17311
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks
|
11 | 11 | $1302.99 | $637.94 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Triamcinolone Acetonide | Triamcinolone Acetonide | 232 | 7,717 | $3,616.51 | 145 |
| Clobetasol Propionate | Clobetasol Propionate | 178 | 5,124 | $7,136.34 | 101 |
| Ketoconazole | Ketoconazole | 114 | 3,557 | $1,987.19 | 66 |
| Hydrocortisone | Hydrocortisone | 79 | 1,859 | $454.24 | 60 |
| Doxycycline Hyclate | Doxycycline Hyclate | 77 | 2,748 | $5,958.08 | 37 |
| Minocycline Hcl | Minocycline Hcl | 50 | 1,382 | $1,021.95 | 29 |
| Fluocinonide | Fluocinonide | 47 | 1,428 | $2,889.46 | 24 |
| Timolol Maleate | Timolol Maleate | 40 | 1,159 | $1,078.17 | 18 |
| Econazole Nitrate | Econazole Nitrate | 28 | 1,078 | $1,023.11 | — |
| Mupirocin | Mupirocin | 24 | 506 | $143.04 | 20 |
| Clindamycin Phosphate | Clindamycin Phosphate | 24 | 885 | $928.80 | 11 |
| Terbinafine Hcl | Terbinafine Hcl | 21 | 450 | $74.57 | — |
| Imiquimod | Imiquimod | 21 | 623 | $529.35 | 14 |
| Gabapentin | Gabapentin | 20 | 840 | $164.94 | — |
| Valacyclovir | Valacyclovir Hcl | 20 | 96 | $165.24 | 12 |
| Skyrizi Pen | Risankizumab-Rzaa | 19 | 1,484 | $399,944.41 | — |
| Calcipotriene | Calcipotriene | 17 | 464 | $1,298.72 | 13 |
| Ivermectin | Ivermectin | 15 | 446 | $4,080.39 | — |
| Tacrolimus | Tacrolimus | 14 | 415 | $2,862.67 | 11 |
| Humira Pen | Adalimumab | 14 | 392 | $95,066.27 | — |
| Dupixent Pen | Dupilumab | 14 | 452 | $58,105.86 | — |
| Metronidazole | Metronidazole | 13 | 535 | $622.53 | — |
| Fluconazole | Fluconazole | 13 | 184 | $123.50 | — |
| Minoxidil | Minoxidil | 13 | 986 | $232.66 | — |
| Opzelura | Ruxolitinib Phosphate | 13 | 420 | $25,908.89 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-05-21NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
NUCC Taxonomy Code: 207ND0101X
The highly-trained surgeons that perform Mohs Micrographic Surgery are specialists both in dermatology and pathology. With their extensive knowledge of the skin and unique pathological skills, they are able to remove only diseased tissue, preserving healthy tissue and minimizing the cosmetic impact of the surgery. Mohs surgeons who belong to the American College of Mohs Surgery (ACMS) have completed a minimum of one year of fellowship training at one of the ACMS-approved training centers in the U.S.
NUCC Taxonomy Code: 207ZP0102X
A pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20080820000731
TX
7719052075
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Skin Cancer Institute Pllc
4709 66th St, Lubbock, TX 794144877
Phone: 8067015844
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Family Nurse Practitioner
Physician Assistant
Physician Assistant (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Dermatology (license number reported to NPPES: TX L2818)
NPI status registered as active in NPPES database
Registered at 4709 66TH ST, LUBBOCK, TX 794144877 (Tel: 8067915844)
Registered at 4709 66TH ST, LUBBOCK, TX 794144877 (Tel: 8067015844)
Recorded as JEFFREY BRACKEEN, M.D.
Dermatology (license number reported to NPPES: TX L2818)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Lubbock
- Dr. Justin Clark, MD
- Dr. Ashley Sturgeon, MD
- Dr. Bryan Harris, MD
- Dr. Brent Paulger, MD
- Dr. Michael Long, MD
- Dr. Jay Truitt, MD, PhD, PharmD, MPH
Mailing Address
4709 66th St
Lubbock, TX 794144877
Phone: 8067015844